A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease
Ein multidimensionaler diagnostischer Ansatz für die chronisch obstruktive Lungenerkrankung
JAMA · 24.06.2025 · 333 (24) · 2164
DOI: 10.1001/jama.2025.7358 ↗Auf einen Blick
Eine neue COPD-Diagnoseschema mit Symptomen und CT-Befunden ordnete einige Personen neu als COPD ein. Diese Gruppe hatte mehr Exazerbationen, höhere Mortalität und schnelleren FEV1-Verlust.
Fragestellung
Erfasst ein multidimensionales COPD-Diagnoseschema mit Symptomen und CT-Befunden zusätzliche Personen mit COPD?
Methode
Kohortenstudie mit 2 longitudinalen Kohorten: COPDGene und CanCOLD; Follow-up bis 31. August 2022 bzw. 31. Dezember 2023.
Ergebnisse
In COPDGene wurden 811 von 5250 Personen ohne Airflow-Obstruktion als COPD neu klassifiziert; 282 von 4166 mit Airflow-Obstruktion nicht mehr. Neu klassifizierte Personen hatten höhere Mortalität, mehr Exazerbationen und schnelleren FEV1-Abfall. In CanCOLD traten mehr Exazerbationen auf.
Schlussfolgerung der Autor:innen
Ein neues diagnostisches COPD-Schema integrierte Atemsymptome, respiratorische Lebensqualität, Spirometrie und strukturelle CT-Befunde und klassifizierte einige Personen neu als COPD.
Kernaussagen
- 811 von 5250 ohne Obstruktion neu als COPD klassifiziert
- Höhere Gesamt- und respiratorische Mortalität sowie mehr Exazerbationen
- Auch einige Personen mit Obstruktion wurden nicht mehr als COPD eingestuft
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 24.06.2025. Verfasst von COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators und 52 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham. Hauptthemen laut MEDLINE: Lung, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NHLBI NIH HHS.
Themen: COPD
Abstract (Originalsprache)
Importance Individuals at risk for chronic obstructive pulmonary disease (COPD) but without spirometric airflow obstruction can have respiratory symptoms and structural lung disease on chest computed tomography. Current guidelines recommend COPD diagnostic schemas that do not incorporate imaging abnormalities.
Objective
To determine whether a multidimensional COPD diagnostic schema that includes respiratory symptoms and computed tomographic imaging abnormalities identifies additional individuals with disease. Design, Setting, and Participants This cohort study included 2 longitudinal cohorts: the Genetic Epidemiology of COPD (COPDGene), which enrolled 10 305 participants between November 9, 2007, and April 15, 2011, with longitudinal follow-up through August 31, 2022; and the Canadian Cohort Obstructive Lung Disease (CanCOLD), which enrolled 1561 participants between November 26, 2009, and July 15, 2015, with follow-up through December 31, 2023. Exposure Exposure included the new multidimensional COPD diagnostic schema, defined by (1) major diagnostic category: presence of the major criterion (airflow obstruction based on postbronchodilator forced expiratory volume in the first second of expiration [FEV 1 ]/forced vital capacity ratio <0.70) and at least 1 of 5 minor criteria (emphysema or bronchial wall thickening on computed tomography, dyspnea, poor respiratory quality of life, and chronic bronchitis); or (2) minor diagnostic category: presence of least 3 of 5 minor criteria (which must include emphysema and bronchial wall thickening for individuals with respiratory symptoms potentially due to other causes). Main Outcomes and Measures All-cause mortality, respiratory cause–specific mortality, exacerbations, and annualized change in FEV 1 .
Results
Among 9416 adults in COPDGene (mean [SD] age at enrollment, 59.6 [9.0] years; 5035 [53.5%] were men; 3071 [32.6%] were Black; 6345 (67.4%) were White; 4943 [52.5%] currently smoked), 811 of 5250 individuals (15.4%) without airflow obstruction were newly classified as having COPD by minor diagnostic category, and 282 of 4166 individuals (6.8%) with airflow obstruction were classified as not having COPD. Reclassified individuals with a new COPD diagnosis had greater all-cause mortality (adjusted hazard ratio, 1.98; 95% CI, 1.67-2.35; P < .001) and respiratory-specific mortality (adjusted hazard ratio, 3.58; 95% CI, 1.56-8.20; P = .003), more exacerbations (adjusted incidence rate ratio, 2.09; 95% CI, 1.79-2.44; P < .001), and more rapid FEV 1 decline (adjusted β = −7.7 mL/y; 95% CI, −13.2 to −2.3; P = .006) compared with individuals classified as not having COPD. Among individuals with airflow obstruction on spirometry, those no longer classified as having COPD based on this new diagnostic schema had outcomes similar to those without airflow obstruction. Among 1341 adults in CanCOLD, individuals newly classified as having COPD experienced more exacerbations (adjusted incidence rate ratio, 2.09; 95% CI, 1.25-3.51; P < .001). Conclusions and Relevance A new COPD diagnostic schema integrating respiratory symptoms, respiratory quality of life, spirometry, and structural lung abnormalities on computed tomographic imaging newly classified some individuals as having COPD. These individuals had an increased risk of all-cause and respiratory-related death, frequent exacerbations, and rapid lung function decline compared with individuals classified as not having COPD. Some individuals with airflow obstruction without respiratory symptoms or evidence of structural lung disease were no longer classified as having COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham.
- Center for Lung Analytics and Imaging Research, University of Alabama at Birmingham, Birmingham.
- Department of Radiology, Duke University Medical Center, Durham, North Carolina.
- University of Texas Health, San Antonio.
- South Texas Veterans Health Care System, San Antonio.
- Respiratory Research Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California.
Förderung
- NIEHS NIH HHS
- NHLBI NIH HHS
Zitieren
APA
COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators, Bhatt, S. P., Abadi, E., Anzueto, A., Bodduluri, S., Casaburi, R., Castaldi, P. J., Cho, M. H., Comellas, A. P., Conrad, D. J., Curtis, J. L., Dass, C., DeMeo, D. L., Dransfield, M. T., San José Estépar, R., Flenaugh, E. L., Foreman, M. G., Fortis, S., Gupta, A., …, & Crapo, J. D. (2025). A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease. JAMA, 333(24), 2164. https://doi.org/10.1001/jama.2025.7358
Vancouver
COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators, Bhatt SP, Abadi E, Anzueto A, Bodduluri S, Casaburi R, et al. A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease. JAMA. 2025;333(24):2164. doi:10.1001/jama.2025.7358
BibTeX
@article{COPDGeneDiagnosisWorkingGroupandCanCOLDInvestigators2025,
author = {COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators, COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators and Bhatt, Surya P and Abadi, Ehsan and Anzueto, Antonio and Bodduluri, Sandeep and Casaburi, Richard and Castaldi, Peter J and Cho, Michael H and Comellas, Alejandro P and Conrad, Douglas J and Curtis, Jeffrey L and Dass, Chandra and DeMeo, Dawn L and Dransfield, Mark T and San José Estépar, Raul and Flenaugh, Eric L and Foreman, Marilyn G and Fortis, Spyridon and Gupta, Arnav and Han, MeiLan K and Hanania, Nicola A and Hersh, Craig P and Hokanson, John E and Humphries, Stephen M and Kirby, Miranda and Kunisaki, Ken M and Li, Pei Zhi and Lynch, David A and MacIntyre, Neil R and Make, Barry J and Mannino, David M and Martinez, Fernando J and McEvoy, Charlene E and Miller, Bruce E and Moll, Matthew and Nakhmani, Arie and Newell, John D and Pratte, Katherine A and Regan, Elizabeth A and Reinhardt, Joseph M and Rennard, Stephen I and Rossiter, Harry B and Strand, Matthew J and Suri, Rajat and Wan, Emily S and Wendt, Christine H and Westney, Gloria E and Wilson, Carla G and Wise, Robert A and Young, Kendra A and Tan, Wan C and Silverman, Edwin K and Crapo, James D},
title = {A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease},
journal = {JAMA},
year = {2025},
volume = {333},
number = {24},
pages = {2164},
doi = {10.1001/jama.2025.7358}
}
EUVIMED